Intended for healthcare professionals


US doctors debate safety of abortifacient drug

BMJ 2006; 332 doi: (Published 12 January 2006) Cite this as: BMJ 2006;332:71
  1. Janice Hopkins Tanne
  1. New York

    Two pro-life doctors in the United States are calling for mifepristone to be withdrawn from the market after looking into reports filed to the Food and Drug Administration of adverse reactions.

    Their request coincided with Senate hearings on the nomination to the Supreme Court of the controversial judge Samuel Alito, who favours ending women's right to abortion.

    The doctors, Margaret Gary and Donna Harrison, members of a subcommittee of the American Association of Prolife Obstetricians and Gynecologists that is looking into the drug, analysed reports of 607 adverse events that they received after a request to the FDA under the terms …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription